Therapeutic vaccines and cancer: focus on DPX-0907

In an attempt to significantly enhance immunogenicity of peptide cancer vaccines, we developed a novel non-emulsion depot-forming vaccine platform called DepoVax™ (DPX). Human leukocyte antigen (HLA)-A2 restricted peptides naturally presented by cancer cells were used as antigens to create a therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Karkada, Mohan, Berinstein, Neil L, Mansour, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930480/
https://www.ncbi.nlm.nih.gov/pubmed/24596453
http://dx.doi.org/10.2147/BTT.S55196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930480/
https://www.ncbi.nlm.nih.gov/pubmed/24596453
http://dx.doi.org/10.2147/BTT.S55196

Ejemplares similares